{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:44:52Z","timestamp":1772120692533,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ebiom.2018.11.016","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T10:32:52Z","timestamp":1542709972000},"page":"238-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-3275","authenticated-orcid":false,"given":"Weifeng","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hejian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiucun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2018.11.016_bb0005","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","article-title":"Fibrosis--a lethal component of systemic sclerosis","volume":"10","author":"Ho","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0015","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1440-1843.2005.00712.x","article-title":"Treatment of idiopathic pulmonary fibrosis: is there anything new?","volume":"10","author":"Abdelaziz","year":"2005","journal-title":"Respirology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1523-1747.1998.00094.x","article-title":"BM-40 (osteonectin, SPARC) is expressed both in the epidermal and in the dermal compartment of adult human skin","volume":"110","author":"Hunzelmann","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0024-3205(96)00035-5","article-title":"Osteonectin gene expression in fibrotic liver","volume":"58","author":"Inagaki","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0945-053X(00)00133-5","article-title":"SPARC, a matricellular protein: at the crossroads of cell-matrix communication","volume":"19","author":"Brekken","year":"2001","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0040","first-page":"847","article-title":"Expression of SPARC in normal and fibrotic livers","volume":"21","author":"Frizell","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0045","first-page":"1759","article-title":"IMMUNOLOCALIZATION of SPARC, TENASCIN, AND THROMBOSPONDIN IN PULMONARY FIBROSIS","volume":"147","author":"Kuhn","year":"1995","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0050","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/ki.1996.520","article-title":"SPARC is expressed in renal interstitial fibrosis and in renal vascular injury","volume":"50","author":"Pichler","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0055","first-page":"651","article-title":"Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts","volume":"151","author":"Blazejewski","year":"1997","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0060","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1091\/mbc.e03-01-0001","article-title":"SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system","volume":"14","author":"Schiemann","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0065","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1002\/art.22249","article-title":"SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor ss stimulation","volume":"54","author":"Zhou","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0070","doi-asserted-by":"crossref","first-page":"L743","DOI":"10.1152\/ajplung.2000.279.4.L743","article-title":"Bleomycin-induced pulmonary injury in mice deficient in SPARC","volume":"279","author":"Savani","year":"2000","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/ar2973","article-title":"Attenuation of fibrosis in vitro and in vivo with SPARC siRNA","volume":"12","author":"Wang","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0080","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/art.21396","article-title":"Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation","volume":"52","author":"Carulli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0085","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/annrheumdis-2016-210426","article-title":"CCL2\/CCR2, but not CCL5\/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis","volume":"76","author":"Raghu","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0090","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.4049\/jimmunol.1302821","article-title":"CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2\/CCR2-dependent gene expression profile","volume":"192","author":"Sierra-Filardi","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0095","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9440(10)62289-4","article-title":"CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury","volume":"166","author":"Moore","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/rheumatology\/ken401","article-title":"Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis","volume":"48","author":"Distler","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)63292-0","article-title":"Blockade of CCR2 ameliorates progressive fibrosis in kidney","volume":"165","author":"Kitagawa","year":"2004","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ebiom.2018.11.016_bb0110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/annrheumdis-2014-205740","article-title":"Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis","volume":"75","author":"Zerr","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0115","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1093\/emboj\/16.17.5353","article-title":"TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4","volume":"16","author":"Nakao","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0120","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/MCB.19.4.2495","article-title":"Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction","volume":"19","author":"Datto","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCULATIONAHA.117.029622","article-title":"Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium","volume":"137","author":"Kong","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0130","series-title":"Annals of the rheumatic diseases","article-title":"S100A4 amplifies TGF-beta-induced fibroblast activation in systemic sclerosis","author":"Tomcik","year":"2014"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0135","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1038\/ncomms5451","article-title":"GIV\/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis","volume":"5","author":"Lopez-Sanchez","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0140","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrd4592","article-title":"Dissecting fibrosis: therapeutic insights from the small-molecule toolbox","volume":"14","author":"Nanthakumar","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0150","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.2174\/1381612811319160004","article-title":"Everything you always wanted to know about CADY-mediated siRNA delivery* (* but afraid to ask)","volume":"19","author":"Konate","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0155","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1096\/fj.14-258459","article-title":"Selective delivery of IFN-gamma to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis","volume":"29","author":"Poosti","year":"2015","journal-title":"FASEB journal"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0160","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1542-3565(05)00404-0","article-title":"Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study","volume":"3","author":"Weng","year":"2005","journal-title":"Clinical gastroenterology and hepatology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0165","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3435","article-title":"Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts","volume":"13","author":"Zhou","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0170","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0175","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/art.39655","article-title":"Toll-like Receptor 9 Signaling is Augmented in Systemic Sclerosis and Elicits Transforming Growth factor beta-Dependent Fibroblast Activation","volume":"68","author":"Fang","year":"2016","journal-title":"Arthritis & rheumatology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0180","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jid.2017.12.003","article-title":"Genome-Wide DNA Methylation Analysis in Systemic Sclerosis reveals Hypomethylation of IFN-Associated Genes in CD4(+) and CD8(+) T Cells","volume":"138","author":"Ding","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0185","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1016\/j.ajpath.2011.08.027","article-title":"SPARC Oppositely Regulates Inflammation and Fibrosis in Bleomycin-Induced Lung damage","volume":"179","author":"Sangaletti","year":"2011","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0190","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0200","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","article-title":"Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model","volume":"185","author":"Yoshizaki","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0210","doi-asserted-by":"crossref","first-page":"44058","DOI":"10.1074\/jbc.M306792200","article-title":"Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation","volume":"278","author":"Rehli","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0215","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1182\/blood-2011-12-398156","article-title":"Genome-wide identification of endothelial cell-enriched genes in the mouse embryo","volume":"120","author":"Takase","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5040045","article-title":"Endothelial to Mesenchymal transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases","volume":"5","author":"Piera-Velazquez","year":"2016","journal-title":"Journal of clinical medicine"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0225","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0230","doi-asserted-by":"crossref","first-page":"13055","DOI":"10.1074\/jbc.271.22.13055","article-title":"Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression","volume":"271","author":"Ye","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0235","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.39476","article-title":"Identification of an Association of TNFAIP3 Polymorphisms with Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis & rheumatology"},{"key":"10.1016\/j.ebiom.2018.11.016_bb0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/thoraxjnl-2013-204596","article-title":"Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis","volume":"70","author":"Depianto","year":"2015","journal-title":"Thorax"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418305097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418305097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:50:23Z","timestamp":1762455023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418305097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":48,"alternative-id":["S2352396418305097"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.016","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/376459","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}